TRUMPF increased sales 3.4 per cent at the end of its 2015/2016 fiscal year, amounting to € 2.81 billion ($414 million CDN).
“We were unable to repeat the strong sales growth of the previous financial year,” says Dr. Nicola Leibinger-Kammüller, chairwoman of the TRUMPF managing board, “but in view of the global economic factors, this result is very satisfactory for an export-oriented company.” In this regard she cites the weak economic situation in China and Brazil, the sanctions against Russia, and also the uncertainty caused by the Brexit referendum, which has also affected other countries, for example in Eastern Europe.
Among the reasons for its sales increase, the company mentioned the development of some regional markets in Western Europe and overseas. TRUMPF achieved double-digit sales growth in Spain (+50 per cent). In France too, sales again reached pre-recession levels (+19.6 per cent), while in Germany, sales rose by 5.2 per cent. In China, the economy was slightly less dynamic, so revenues there totaled around €368 million, a decrease of roughly 0.5 per cent compared to the previous year. The USA remained similarly stable (+0.3 per cent to €370 million).
Leibinger-Kammüller went on to say that over the past year, TRUMPF has driven targeted investments in the future, including the development of new machines, the founding of a venture capital company to support startups, as well as structural expansion of its locations in Germany and abroad. In total, the company invested €138 million (+6.3 per cent compared to last year), partially in structural expansion, and also acquired software companies such as Xetics in Stuttgart and C-Labs in the USA to strengthen its digital strategy.
Moreover, TRUMPF is aiming at a significant personnel increase in the area of additive manufacturing. Leibinger-Kammüller mentioned that up to 100 new jobs would be created during the current fiscal year, most of them in Ditzingen, and a further increase of at least 100 more is planned for the coming fiscal year of 2017/18.
Expenditure on research and development was further increased during the fiscal year 2015/16 in a targeted manner, rising by +11.7 percent to €296 million (previous year: €265 million). The development ratio in relation to sales rose to 10.5 percent (previous year: 9.8 percent).
For the current fiscal year, the company is aiming for sales growth in the medium single-digit percentage range.